Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-TECHNE Corp Director's Dealing 2014

Dec 12, 2014

30718_dirs_2014-12-12_3b04bfd2-8e0d-479a-aedc-f27b6f68118a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2014-12-10

Reporting Person: HOLBROOK KAREN A (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-12-10 Common Stock S 1000 $92.4 Disposed 1000 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option $91.78 2024-10-30 Common Stock (4000) 4000 Direct
Stock Option $87.39 2023-10-30 Common Stock (4000) 4000 Direct
Stock Option $66.9 2022-10-24 Common Stock (5000) 5000 Direct
Stock Option $70.35 2021-10-26 Common Stock (5000) 5000 Direct
Stock Option $61.46 2020-10-27 Common Stock (5000) 5000 Direct
Stock Option $63.03 2019-10-28 Common Stock (5000) 5000 Direct
Stock Option $65.47 2018-10-22 Common Stock (5000) 5000 Direct
Stock Option $66.59 2017-10-24 Common Stock (5000) 5000 Direct